Upcoming KTM 390 Enduro R spotted ahead of EICMA unveil

The upcoming KTM 390 Adventure range has been making a lot of news. If anyone has been following closely, the range also consists of an Enduro model called the KTM 390 Enduro R. This particular motorcycle was spotted in full ahead of its official EICMA unveil, and here are all the exciting details.

New KTM 390 Enduro R: Details

The KTM 390 Enduro R uses a trellis frame and sports a similar design to all other Enduro models from KTM, with a small headlight cowl, a slim profile, and minimal plastic bodywork. The motorcycle spotted ahead of EICMA reveals a single flat seat – a big differentiator compared to the upcoming 390 Adventure R – and the front cowl design, as the ADV gets a large windshield.

Also ReadKTM 390 Adventure new vs old — Three big differences

The new KTM 390 Enuro R will ride on 21-inch front and 18-inch rear spoke wheels as compared to the ADV, which gets a 17-inch rear wheel. The motorcycle gets USD forks at the front and a a monoshock at the rear, while the handlebar position is also different compared to the 390 Adventure R.

KTM 390 Enduro R: Engine specifications

The engine will be the 399cc unit that powers the 390 Duke currently. The engine makes 45.3bhp and 39Nm of torque mated to a 6-speed gearbox. This will be the same engine that the 390 Adventure R and the 390 Adventure will get, however, there could be slight changes to the gearing with the Enduro R model, which we will get to know more in the coming days.

The KTM 390 Enduro R might not come to India, which is a bummer. European markets have a huge interest in Enduro models and KTM’s sales will be focused there with this motorcycle. However, if it does come to India along with the 390 Adventure models, it will be an exciting move for enthusiasts.

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations